Gene: GJB4
Official Full Name: gap junction protein beta 4provided by HGNC
Gene Summary: This gene encodes a transmembrane connexin protein that is a component of gap junctions. Mutations in this gene have been associated with erythrokeratodermia variabilis, progressive symmetric erythrokeratoderma and hearing impairment. [provided by RefSeq, Dec 2009]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO07397 | GJB4 Knockout cell line (HCT 116) | Human | GJB4 | 1:2~1:4 | Negative | Online Inquiry |
GJB4 Gene Knockout Cell Lines are genetically modified cell lines specifically engineered to lack the expression of the GJB4 gene, which encodes the gap junction protein connexin 30. This innovative biological product facilitates comprehensive studies on gap junction intercellular communication and its implications in various physiological and pathological processes. By creating a knockout model, researchers can elucidate the role of GJB4 in cellular functions, including those related to hearing, skin homeostasis, and certain neurological conditions.
The primary function of the GJB4 gene knockout cell lines is to serve as a versatile tool for investigating the mechanisms through which gap junctions influence cellular communication, tissue homeostasis, and response to stressors. These cell lines functionally lack connexin 30, allowing for insights into compensatory mechanisms that might arise in its absence and how these changes impact signaling pathways and cellular behaviors.
The scientific importance of GJB4 knockout models is underscored by their applications in research settings, especially in studies related to deafness, skin diseases, and other connexin-related disorders. They provide a powerful experimental system to assess therapeutic interventions and gene therapy approaches aimed at restoring normal gap junction function. Furthermore, these cell lines can be employed in high-throughput screening assays, enabling accelerated drug discovery processes that target connexin-related pathways.
Compared to alternative models, GJB4 Gene Knockout Cell Lines offer several advantages, including precise control over genetic background and well-characterized phenotypic responses. While traditional models may not capture the nuances of gene function, our knockout cell lines exhibit clear markers for the absence of GJB4 expression, promoting reproducible and reliable results which are critical for scientific investigations.
For researchers and clinicians seeking to understand the complexities of gap junction dynamics and their implications in health and disease, GJB4 Gene Knockout Cell Lines represent an invaluable resource. Our commitment to advancing biotechnology is fortified by our expertise in developing state-of-the-art genetic models, ensuring that our offerings are grounded in rigorous scientific validation and innovation.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.